Basic Information
IGANTET INJECTION 250 iu/ml
INJECTION
Regulatory Information
SIN12556P
June 24, 2004
Prescription Only
Therapeutic
INTRAMUSCULAR
August 10, 2023
June 3, 2025
XJ06BB02
Company Information
Active Ingredients
ANTITETANUS IMMUNOGLOBULIN (HUMAN)
Strength: 250 iu/ml
Detailed Information
Contraindications
**Contraindications** The lethal risk associated with tetanus rules out any potential contraindication (see item corresponding to Precautions – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).
Indication Information
**Therapeutic indications** - Prophylaxis in persons with recent injuries that might be contaminated with tetanus spores and who did not receive vaccination in the previous 10 years or whose prior vaccination regimen was incomplete or is unknown. - Treatment of clinically manifest tetanus.